Short answer
Sionna Therapeutics, Inc. (SION) filed an 8-K current report with the SEC on March 2, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Full-year 2025 financial results disclosed via press release (Exhibit 99.1) dated March 2, 2026.
Sionna Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Full-year 2025 financial results disclosed via press release (Exhibit 99.1) dated March 2, 2026
- Investors should review Exhibit 99.1 for key figures including cash runway, R&D spend, and pipeline updates
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Sionna Therapeutics, Inc. 8-K filings
Get the next SION 8-K as it lands
Follow SION for push alerts, or ask the research agent what this filing means.